ProPublica

Journalism in the Public Interest

Cancel

ViiV

ViiV was created in October 2009 to manage the HIV/AIDS medications of GlaxoSmithKline and Pfizer. Glaxo has an 85% ownership interest and Pfizer 15%. In 2012, Shionogi & Co. took an equity interest in the company. Like Glaxo, ViiV is based in the United Kingdom, with U.S. headquarters in Research Triangle Park, N.C.

ViiV reports payments made to physicians for speaking and consulting beginning in January 2010. In 2010, it began reporting research payments in a separate report.

See all ViiV payments, or visit ViiV's transparency page.

Payment Reports

2010 Jan. to Dec.

Avg. Quarterly Total
Speaking $993,776 $3,975,102
Consulting $89,438 $357,750
$1,083,213 $4,332,852

2010 Jan. to Dec. Research

Avg. Quarterly Total
Research $877,783 $3,511,131
$877,783 $3,511,131

2011 Jan. to Dec.

Avg. Quarterly Total
Speaking $722,846 $2,891,383
Consulting $57,034 $228,135
$779,880 $3,119,518

2011 Jan. to Dec. Research

Avg. Quarterly Total
Research $1,425,170 $5,700,681
$1,425,170 $5,700,681

2012 Jan. to Sept.

Avg. Quarterly Total
Speaking $547,283 $1,641,850
Consulting $15,500 $46,500
$562,783 $1,688,350

Total Payments by State

State Total
California $3,510,987
New York $2,830,305
Texas $2,645,506
Florida $1,252,676
Maryland $1,101,610
Minnesota $974,277
Pennsylvania $652,981
North Carolina $492,837
Illinois $487,436
District of Columbia $433,040
Colorado $415,264
New Jersey $386,880
Georgia $377,262
Missouri $258,241
Connecticut $237,703
Arizona $237,289
Massachusetts $200,641
Michigan $195,363
North Dakota $155,302
Wisconsin $144,603
Washington $139,152
Tennessee $134,425
Alabama $133,162
Virginia $115,482
Ohio $112,850
Nevada $104,500
Rhode Island $82,239
Indiana $73,148
Idaho $67,265
Puerto Rico $66,900
Kansas $63,070
Arkansas $62,039
South Carolina $51,722
Oregon $33,884
Iowa $32,896
Mississippi $23,874
Oklahoma $18,800
Hawaii $18,550
New Mexico $8,500
Utah $5,715
Maine $4,300
Nebraska $4,133
Louisiana $2,224
New Hampshire $2,000
Kentucky $1,500